Early Detection and First Episode Care
Studies on screening pathways, early intervention models, and long-term functional outcomes after first episode psychosis.
Contribute clinically meaningful schizophrenia research designed to improve real-world decisions across medical and clinical practice.
We invite clinically relevant manuscripts that improve diagnosis, treatment pathways, clinical outcomes, and long-term patient quality of life.
Journal of Schizophrenia Disorders And Therapy welcomes rigorous submissions in psychosis care, schizophrenia therapeutics, translational psychiatry, public mental health, and implementation science.
Priority is given to studies that combine methodological strength with practical implications for decision making in clinics, community services, and multidisciplinary treatment planning.
The journal values evidence that advances standards of care, strengthens risk stratification, and clarifies outcomes across diverse patient populations and healthcare settings.
Studies on screening pathways, early intervention models, and long-term functional outcomes after first episode psychosis.
Comparative effectiveness research on antipsychotic strategies, adverse effects, adherence, and relapse prevention.
Evidence on CBT, family support, social rehabilitation, and integrated recovery-oriented care pathways.
Research linking biological markers, neurocognitive patterns, and symptom trajectories to treatment decisions.
Evaluations of telepsychiatry, remote monitoring, and care pathway redesign in real-world systems.
Age-specific intervention studies addressing transition from child to adult services and long-term continuity of care.
Editorial triage and review prioritize transparent methods, defensible interpretation, and clinical relevance.
Authors are encouraged to describe implementation context, including service constraints and resource conditions, so readers can evaluate transferability of findings.
Multicenter submissions should clarify center-level variation handling and protocol harmonization strategy to strengthen reproducibility claims.
Multiple manuscript categories are accepted when evidence quality and reporting standards are met.
Prospective or retrospective analyses with robust methodology and clinically interpretable outcomes.
Protocol-based evidence synthesis with transparent search and selection logic.
Mechanistic or biomarker studies linked to diagnostic or therapeutic decision value.
Operational research on pathway redesign, quality improvement, and access optimization.
Focused findings with immediate relevance and strong methodological framing.
Evidence-grounded expert viewpoints on evolving standards and strategic priorities.
Both submission options are supported by the same editorial team and quality framework.
Recommended for teams needing structured data fields, formal revision tracking, and institutional workflow compatibility.
Suitable for rapid initial intake when authors require a streamlined process and direct communication.
Scope and formatting questions can be sent to [email protected] before submission to reduce avoidable delays.
After submission, manuscripts move through editorial screening, specialist reviewer assignment, and decision communication with actionable revision priorities.
High-quality studies that align with these priorities are positioned for global open access visibility through the journals indexing ecosystem.
High-impact manuscripts typically explain how findings alter diagnosis, treatment selection, or patient pathway planning in real practice.
Authors should state endpoint hierarchy clearly so reviewers can assess interpretive strength without ambiguity.
Submissions addressing underserved populations and implementation barriers are strongly encouraged.
Structured reporting improves review efficiency and reduces avoidable revision cycles.
Collaborative multicenter studies are welcome when data governance and method consistency are clearly documented.
High-impact manuscripts typically explain how findings alter diagnosis, treatment selection, or patient pathway planning in real practice.
Authors should state endpoint hierarchy clearly so reviewers can assess interpretive strength without ambiguity.
Submissions addressing underserved populations and implementation barriers are strongly encouraged.
Structured reporting improves review efficiency and reduces avoidable revision cycles.
Collaborative multicenter studies are welcome when data governance and method consistency are clearly documented.
High-impact manuscripts typically explain how findings alter diagnosis, treatment selection, or patient pathway planning in real practice.
Authors should state endpoint hierarchy clearly so reviewers can assess interpretive strength without ambiguity.
Submissions addressing underserved populations and implementation barriers are strongly encouraged.
Structured reporting improves review efficiency and reduces avoidable revision cycles.
Collaborative multicenter studies are welcome when data governance and method consistency are clearly documented.
High-impact manuscripts typically explain how findings alter diagnosis, treatment selection, or patient pathway planning in real practice.
Authors should state endpoint hierarchy clearly so reviewers can assess interpretive strength without ambiguity.
Submissions addressing underserved populations and implementation barriers are strongly encouraged.
Structured reporting improves review efficiency and reduces avoidable revision cycles.
Choose your preferred submission workflow and move your manuscript into a rigorous, clinically focused peer review process.
Editorial office: [email protected]